Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Invest with CPF/SRS
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

19.94
-0.9400-4.50%
Post-market: 20.010.0610+0.31%19:58 EDT
Volume:4.79M
Turnover:97.13M
Market Cap:2.02B
PE:-4.32
High:21.19
Open:20.79
Low:19.74
Close:20.88
52wk High:35.25
52wk Low:13.53
Shares:101.16M
Float Shares:89.94M
Volume Ratio:1.19
T/O Rate:5.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6207
EPS(LYR):-4.5769
ROE:-41.94%
ROA:-21.02%
PB:1.93
PE(LYR):-4.36

Loading ...

OverviewCompanyNewsFilings

Beam Therapeutics Inc - Ends Q2 2025 With $1.2 Bln Cash; Runway Into 2028

THOMSON REUTERS
·
Aug 05

FMR LLC Reports Disposal of Common Shares of Beam Therapeutics Inc

Reuters
·
Aug 01

AI Biotech Stocks Shined. Recursion Soared 10%; Absci Up 7%; Crispr Up 6%; Beam And Ginkgo Up 3%

Tiger Newspress
·
Jul 21

Chief Medical Officer Simon Amy Reports Disposal of Common Shares of Beam Therapeutics Inc

Reuters
·
Jul 04

BRIEF-Beam Therapeutics Buys Early-Stage Life Sciences Company

Reuters
·
Jul 04

Beam Therapeutics Inc. Issues 403,128 Shares as Upfront Payment and Announces Potential Additional Milestone Shares Worth Up to $89 Million in Acquisition Deal

Reuters
·
Jul 04

Beam Therapeutics Announces Promising New Data from BEACON Phase 1/2 Trial of BEAM-101 for Sickle Cell Disease at EHA 2025 Congress

Reuters
·
Jun 13

BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Hewlett Packard Enterprise, Venture Global

Reuters
·
Jun 04

Beam Therapeutics Inc. Receives FDA Orphan Drug Designation for BEAM-101 in Sickle Cell Disease Treatment

Reuters
·
Jun 03
More

Analyst Rate

Buy
Buy
87.50%
Hold
12.50%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 05, 2025 Pre-Market
Financial Report Announcement
May 06, 2025 Pre-Market
Financial Report Announcement
Feb 25, 2025 Pre-Market
Financial Report Announcement
Nov 05, 2024 Pre-Market
Financial Report Announcement
Aug 06, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-4.57
Current
-13.50
Sector Average
94.30%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-4.57
Maximum
-3.54
+1 STD
-5.11
Minimum
-52.08
-1 STD
-21.88
Average
-13.50

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.